In addition to GMP manufacturing, the facility includes laboratories specifically designed for gene therapy research and development. IGEN expects to file summary judgment motions on additional claims as the litigation progresses. Under the terms of the settlement both companies agree to dismiss all suits and countersuits in the federal and state court actions and to cross-license selected patents. The tumor cells took up the cell-death gene, and the drug successfully caused controlled death and elimination of the prostate cancer cells. Such Information is neither an offer to sell nor a solicitation to buy the securities of any company.
Additional information is available upon request.
Information in this publication has been obtained from sources believed to be reliable, but the accuracy, completeness and interpretation are not guaranteed. Opinions expressed are subject to change without notice. BioSpace, and BioSpace's employees and officers, as well as Wayne Hummer Investments LLC, and Wayne Hummer Investments LLC 's employees and officers, in no way accept responsibility for any of the Newsletter's content. The Information is supplied on the condition that the reader or any other person receiving the Information will make his or her own determination as to its suitability for any purpose prior to any use of the Information. Also BioSpace, Inc. and Wayne Hummer Investments LLC may, from time to time solicit business from any company mentioned in this report.